Announced completion of dose exploration portion of ORIC-944 Phase 1b clinical trial and presented data that continues to demonstrate potential ...

Q3 U.S. Galleri Revenue Grew 28% Year-Over-Year to $32.6 Million Q3 Galleri Tests Sold Grew 39% Year-Over-Year to More Than 45,000 Galleri PMA Submission ...

Announced completion of dose exploration portion of ORIC-944 Phase 1b clinical trial and presented data that continues to demonstrate potential best-in-class efficacy and safety Bolstered leadership ...

TUBAJON, Dinagat Islands (MindaNews / 13 November) — A key component of the Dinagat Communities for Conservation (C4C) ...

Public Storage boasts a strong balance sheet with $20B in assets, $48B market cap, and 3,491 properties. PSA maintains high ...

An increase of more than 0.75 ng/mL has also been considered as a cutoff to begin a more thorough workup. However, the PSA ...

SAN ANTONIO — In the course of caring for individuals with psoriasis, clinicians should have patients complete the validated ...

I am a 68-year old male in good health who exercises regularly, doesn’t take any medications, and doesn’t have a family history of prostate cancer. During my most recent yearly physical exam with my ...

ANSWER: The prostate specific antigen (PSA) test is a way to screen for prostate cancer. It is not perfect, but when used properly, it can save lives by identifying men who have early prostate cancer ...

“As a two-time prostate cancer survivor, I enjoy today as if it will be my last,” Jesse said. “I engage every man I meet ...

I am a 68-year old male in good health who exercises regularly, doesn’t take any medications, and doesn’t have a family ...

Prostate cancer is the most common cancer among men, and it's the second leading cause of cancer death for men in the U.S.